in the etiology of essential hypertension and at present the primary cause of this disease remains obscure. The relationship of sodium to the development of hypertension and the question of involvement of the adrenal cortex has been the subject of numerous investigations. Efforts by earlier investigators to show a hypersecretion of corticosteroids in this condition were conflicting and the general conclusions were that there was no consistent abnormality in adrenal cortical function in this disease. With the isolation of aldosterone, a highly active, naturally occurring sodium-retaining hormone, interest has been renewed in the relationship of the adrenal cortex to hypertension. An elevated blood pressure is the usual finding in patients with primary aldosteronism,l and the administration of aldosterone to normal individuals and to patients with Addison's disease over periods of 2 to 3 weeks results in a rise in blood pressure.23 Genest et al.4 have reported that 55 per cent of patients with essential, renal, and malignant hypertension, excrete amounts of aldosterone in the higher range or above normal levels. In a more recent study, using an isotope-dilution technic, Laragh and co-workers7 found the secretion rate of aldosterone to be within the normal range in patients with benign essential hypertension. In hypertensive patients with renal or vascular complications, the secretion was significantly increased.
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In the present study a survey was made of the levels of urinary aldosterone and its reduced metabolite in normal individuals and in patients with essential hypertension in whom the sodium intake was known. A small group of patients with malignant and renal hypertension was also investigated. Most of the patients were followed from 2 to 6 days in the hospital. The response of plasma and urinary 17-hydroxycorticosteroids and urinary aldosterone to the administration of adrenocorticotrophic hormone (ACTH) was investigated and in addition the steroid content of the adrenal glands obtained at autopsy from two patients with malignant hypertension was determined.
Methods Aldosterone was extracted from urine after hydrolysis at pH 1.5 at room temperature for 48 hours. The fraction containing aldosterone was purified on paper in four chromatographic systems as outlined by Dyrenfurth and Venning8 and was measured by reduction with blue tetrazolium.
The tetrahydro derivative of aldosterone was hydrolyzed by means of /3-glucuronidase and was isolated and determined after acetylation by the reduction of blue tetrazolium according to a modification of the procedure of Ulich and Lieberman. 9 The details of this method will be published by Dyrenfurth et al. 10 Urinary 17-hydroxycorticosteroids were determined by the Porter-Silber method' and the plasma 17-hydroxycorticosteroids by the method of Bush and Silber.12 The pattern of corticosteroid excretion was examined in two patients with essential hypertension, and the steroid content of adrenal tissue from two patients with malignant hypertension by procedures previously outlined by Dyrenfurth and co-workers.13 14 The functional capacity of the adrenal gland to respond to the administration of adrenocorticotrophic hormone was determined in 5 patients with essential hypertension and was compared with responses obtained in normotensive individuals. 15 The normal subjects and the hypertensive patients were studied either in the metabolic unit or in the general medical wards of the Royal Victoria Hospital. In the former instance complete metabolic balance technics were followed and the dietary composition was determined from food tables with periodic checking of sample diets. The It has been customary to classify hypertension into a primary and a secondary form, the former being largely a diagnosis of exclusion. The patients described in this study were carefully investigated from the clinical point of view. Meticulous inquiry into the family history as well as into a previous history of renal disease was made. In all patients urinalysis and routine hematologic studies were performed as well as an electrocardiogram, a radiologic examination of the chest, and an intravenous pyelogram. Nonprotein nitrogen or serum creatinine, serum sodium, potassium, chloride, and bicarbonate determinations were carried out in all patients. In most of the individuals studied a phentolamine (Regitine) test was carried out as a screening procedure for pheochromocytoma, as well as a tetraethyl ammonium chloride test (TEAC) as a screening procedure for unilateral renal vascular disease. Urinary catecholamines were determined when indicated, as were repeated urine cultures when clinical or laboratory evidence suggested the presence of a pyelonephritis. In many patients an endogenous creatinine clearance, as an index of glomerular filtration rate, was determined, as well as a 10 ml. intravenous phenolsulfonphthalein test with collection of urines at 15, 30, 60, and 120 minutes. In patients in whom hypertension secondary to a unilateral renal vascular lesion was suspected, aortography and differential renal function studies as described by Howard23 were performed. Although the pitfalls of any attempt to classify patients with hypertension are well recognized, it was considered that there was some merit in subdividing these hypertensive subjects into the following categories:
1. Essential hypertension without clinical and laboratory evidence of renal disease.
2. Essential hypertension with renal disease. These were patients with a previous diagnosis of essential hypertension who developed laboratory evidence compatible with arteriolar nephroselerosis. 4. Malignant hypertension. These individuals had an accelerated form of hypertension associated with progressive renal damage, retinopathy, and papilledema.
The distinctions made in these four categories were based on the belief that they probably represent a progressive advance in the severity of the disease. There is as yet a lack of information concerning the effect of alterations in renal functional capacity upon aldosterone excretion by the adrenal cortex.
5. Hypertension associated with generalized arteriosclerosis. 6 . Hypertension with associated heart failure. This group was separated because it was thought that the syndrome of congestive heart failure in itself elevates the urinary aldosterone excretion.
7. Hypertension associated with pheochromocytoma. The sodium intake in these cases was controlled but only a limited number were placed on complete metabolic studies, the results of which will be reported in a subsequent communication.
The clinical report of the two cases with malignant hypertension whose adrenal glands were analyzed for their steroid content (table  1) is as follows:
Case 1 was an obese man, aged 42 years, with severe hypertension, who had been treated for several months with reserpine, chlorothiazide, and a low-sodium diet. Since he was unreliable, he probably did not follow his treatment. He suffered a cerebral hemorrhage, was admitted to the hospital in an unconscious state, and died that night. An autopsy was performed 20 hours after death and showed the following pathologic changes: subarachnoid hemorrhage, hypertrophy and dilatation of the heart, malignant nephroselerosis, arteriolar sclerosis and necrosis of the adrenal glands, liver, and spleen, and adrenal cortical hyperplasia, nod-1ENNING, DYRENFURTH, DOSSETOR, BECK Results The results of the survey are shown in table 2. Forty-six patients with hypertension were studied and a total of 147 assays of aldosterone was made. Twenty-six of these patients presented a picture of essential hypertension without clinical and laboratory evidence of renal disease. They were divided into two groups, depending upon their sodium intake. This varied from 100 to 150 mEq. per day in the first group and from 70 to 85 mEq. per day in the second group. In the normotensive group the estimated sodium intake was between 100 and 170 mEq. per day.
The healthy individuals excreted amounts of aldosterone ranging from 2 to 12 jug. per day, with a mean value of 5.1 ± S.E. 0. 22 Figure 2 Fluctuations in daily urinary aldosterone levels in normal subjects and in patients with essential hypertension on a known sodium intake.
range and one patient with hypertension and heart failure also showed a normal output of aldosterone. A second patient in this group on a sodium intake of 70 to 85 mEq. had values ranging from 11.6 to 18.7 jug. per day. In the two patients with proved pheochromocytoma, the aldosterone output was within the normal range.
In each group of hypertensive patients the mean aldosterone excretion was always higher with the lower sodium intake. In general the severity of the disease tended to be greater, so that it is perhaps not justifiable to attempt to assess the influence of the lower sodium intake on aldosterone excretion in these cases. When hypertensive patients were followed daily for periods of 4 to 6 days, it became evident that many showed wider fluctuations in aldosterone excretion than normotensive individuals. Approximately 30 per cent of the cases studied showed these fluctuations. The daily aldosterone excretions in five hospitalized normotensive and five hypertensive subjects that showed these fluctuations are depicted in figure 2 .
The amount of aldosterone extracted from urine at pH 1.5 represents only a small fraction of the amount elaborated by the adrenal gland. Part Figure 4 Pattern of excretion of corticosteroids in a patient with essential hypertension.
teroids and aldosterone were in the same range after the administration of adrenocorticotrophic hormone. The plasma levels of 17-hydroxycorticosteroids before and after adrenocorticotrophic hormone in both groups fell within the same range. These studies indicate that the adrenal glands of patients with essential hypertension are not more responsive to adrenocorticotrophin than those of normotensive individuals.
Steroid Content of Adrenal Glands of Patients with Malignant Hypertension
Adrenal glands from the two patients with malignant hypertension were analyzed for Although the determination of the tetrahydro derivative does not appear to have the same accuracy as that for aldosterone, the mean value in a group of six patients with essential hypertension was considerably higher than that observed in normotensive individuals, 40 per cent of the values being above the highest value obtained in the normal group. The number of patients studied, however, was small compared to the number of normal individuals, and this ratio might change with an increasing number of assays. Very high amounts of the tetrahydro derivative were found in the urine of a patient with glomerulonephritis on a sodium intake of 100 mEq. per day.
Several possible explanations for the wide fluctuations in the urinary excretion of aldosterone that occur in some patients with hypertension can be suggested. These may reflect a variation in the secretion rate or an alteration in the metabolic degradation of aldosterone and its urinary excretion. If Several studies with a variety of methods 19, 20 have failed to show an increase in the excretion of corticosteroids in essential hypertension, and in the present study the PorterSilber corticosteroids were within the normal range. Fractionation of the individual steroids also failed to show any gross abnormality in the ratio of the different urinary corticosteroids.
The high amount of aldosterone found in the adrenal glands of the two patients with malignant hypertension suggests that these glands have been secreting excessive amounts of this hormone at the time of death. These amounts are higher than those reported by Neherl6 in tumors from patients with primary aldosteronism and only slightly lower than that observed by Genest21 in a case of primary aldosteronism and adrenal hyperplasia. In this case the adrenal gland was removed surgically, and a content of 3.6 [,g. aldosterone per gram of tissue was found.
These studies suggest that aldosterone may play some role in the etiology of essential hypertension but a direct causal relationship seems unlikely. The 
